After years of receiving reports of painful complications from thousands of women, the U.S. Food and Drug Administration (FDA) has placed new restrictions on a permanent contraceptive implant known as Essure.
The sale and implantation of the permanent birth control device, Essure, which has led to the death of at least four women and causes pain so severe some women report becoming suicidal, has been suspended in the EU for three months pending additional information.
Only after dozens of deaths and thousands of lawsuits has the Food and Drug Administration (FDA) decided to revisit the safety of newer versions of birth control pills.
By Susan Brinkmann, OCDS
The Food and Drug Administration (FDA) has announced the launching of an investigation into oral contraceptives such as Yaz and Yasmin that contain drospirenone after new research suggests these pills increase the risk of blood clots more than other oral contraceptives.